297 related articles for article (PubMed ID: 31575911)
1. Diagnostic contribution of metabolic workup for neonatal inherited metabolic disorders in the absence of expanded newborn screening.
Bower A; Imbard A; Benoist JF; Pichard S; Rigal O; Baud O; Schiff M
Sci Rep; 2019 Oct; 9(1):14098. PubMed ID: 31575911
[TBL] [Abstract][Full Text] [Related]
2. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of organic acidemia in neonates from neonatal intensive care units].
Xu FL; Fan T; Duan JJ; Chen D
Zhongguo Dang Dai Er Ke Za Zhi; 2012 May; 14(5):336-9. PubMed ID: 22613102
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic challenges of aminoacidopathies and organic acidemias in a developing country: a twelve-year experience.
Karam PE; Habbal MZ; Mikati MA; Zaatari GE; Cortas NK; Daher RT
Clin Biochem; 2013 Dec; 46(18):1787-92. PubMed ID: 23994778
[TBL] [Abstract][Full Text] [Related]
5. Inherited metabolic disorders in the neonatal intensive care unit: Red flags to look out for.
Eminoğlu FT; Koç Yekedüz M; Doğulu N; Öncül Ü; Köse E; Okulu E; Erdeve Ö; Atasay B; Arsan S
Pediatr Int; 2022 Jan; 64(1):e14953. PubMed ID: 34390086
[TBL] [Abstract][Full Text] [Related]
6. [Screening of the Westphalia-Lippe newborns of 1977 for phenylketonuria, histidinemia, homocystinuria and maple syrup disease. Furthermore a pilot study of galactosemia and galactokinase deficiency disease].
Menne F; Otte HJ; Krüger M; Winterhoff D
MMW Munch Med Wochenschr; 1979 Jun; 121(25):833-4. PubMed ID: 111089
[No Abstract] [Full Text] [Related]
7. Untargeted metabolomic analysis of urine samples for diagnosis of inherited metabolic disorders.
Liu H; Zhu J; Li Q; Wang D; Wan K; Yuan Z; Zhang J; Zou L; He X; Miao J
Funct Integr Genomics; 2021 Nov; 21(5-6):645-653. PubMed ID: 34585279
[TBL] [Abstract][Full Text] [Related]
8. An Economic Evaluation of Neonatal Screening for Inborn Errors of Metabolism Using Tandem Mass Spectrometry in Thailand.
Thiboonboon K; Leelahavarong P; Wattanasirichaigoon D; Vatanavicharn N; Wasant P; Shotelersuk V; Pangkanon S; Kuptanon C; Chaisomchit S; Teerawattananon Y
PLoS One; 2015; 10(8):e0134782. PubMed ID: 26258410
[TBL] [Abstract][Full Text] [Related]
9. Spectrum Analysis of Inherited Metabolic Disorders for Expanded Newborn Screening in a Central Chinese Population.
Li X; He J; He L; Zeng Y; Huang X; Luo Y; Li Y
Front Genet; 2021; 12():763222. PubMed ID: 35095998
[TBL] [Abstract][Full Text] [Related]
10. Screening for neonatal inherited metabolic disorders by tandem mass spectrometry in Guangzhou.
Tang C; Tan M; Xie T; Tang F; Liu S; Wei Q; Liu J; Huang Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 50(4):463-471. PubMed ID: 34704419
[TBL] [Abstract][Full Text] [Related]
11. Bloodspot acylcarnitine and amino acid analysis in cord blood samples: efficacy and reference data from a large cohort study.
Walter JH; Patterson A; Till J; Besley GT; Fleming G; Henderson MJ
J Inherit Metab Dis; 2009 Feb; 32(1):95-101. PubMed ID: 19191006
[TBL] [Abstract][Full Text] [Related]
12. Biochemical testing for inborn errors of metabolism: experience from a large tertiary neonatal centre.
Dunne E; O'Reilly D; Murphy CA; Howard C; Kelleher G; Suttie T; Boyle MA; Brady JJ; Knerr I; Khuffash AE
Eur J Pediatr; 2022 Oct; 181(10):3725-3732. PubMed ID: 35945291
[TBL] [Abstract][Full Text] [Related]
13. [Newborn screening in France: news and perspectives].
Gernez E; Roland E; Dhaenens CM; Renom G; Mention K
Ann Biol Clin (Paris); 2024 Apr; 82(1):24-31. PubMed ID: 38638016
[TBL] [Abstract][Full Text] [Related]
14. Neonatal Macrosomia is an Interfering Factor for Analytes on the Colorado State Newborn Screen.
Wright EL; Baker PR
J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 32126138
[TBL] [Abstract][Full Text] [Related]
15. Current approaches to genetic metabolic screening in newborns.
Levy HL; Cornier AS
Curr Opin Pediatr; 1994 Dec; 6(6):707-11. PubMed ID: 7849819
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI
Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535
[TBL] [Abstract][Full Text] [Related]
17. Clinical Presentation of Inherited Metabolic Diseases in Newborns Hospitalised in an Intensive Care Unit.
Teixeira C; Cordeiro C; Pinto C; Diogo L
J Mother Child; 2023 Jun; 27(1):55-63. PubMed ID: 37843971
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from South-West Germany.
Lindner M; Gramer G; Haege G; Fang-Hoffmann J; Schwab KO; Tacke U; Trefz FK; Mengel E; Wendel U; Leichsenring M; Burgard P; Hoffmann GF
Orphanet J Rare Dis; 2011 Jun; 6():44. PubMed ID: 21689452
[TBL] [Abstract][Full Text] [Related]
19. Implications of Maple Syrup Urine Disease in Newborns.
Harris-Haman P; Brown L; Massey S; Ramamoorthy S
Nurs Womens Health; 2017; 21(3):196-206. PubMed ID: 28599741
[TBL] [Abstract][Full Text] [Related]
20. Neonatal screening in Italy for congenital hypothyroidism and metabolic disorders: hyperphenylalaninemia, maple syrup urine disease and homocystinuria.
Antonozzi I; Dominici R; Andreoli M; Monaco F
J Endocrinol Invest; 1980; 3(4):357-63. PubMed ID: 7204885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
